RAM Pharmaceuticals is advancing two breakthrough medications: Triamdocaine, a novel therapy for radiation and chemotherapy-induced Severe Oral Mucositis in cancer patients, and Acyclonine MUM, a dentist-prescribed solution for rapid relief of painful oral lesions.
RAM Pharmaceuticals is a clinical-stage company driven by a clear mission: cancer treatment shouldn't rob patients of life's simplest joys—sharing a laugh, enjoying a meal, or whispering, "I love you." Through our Cancer Comfort Care Initiative, we are restoring dignity and bringing relief to those undergoing the fight of their lives.

Our flagship product, Triamdocaine, delivers precise, localized relief to help cancer patients reclaim their quality of life. With FDA IND approval secured, we are advancing innovation in supportive cancer care.

Beyond oncology, our commitment extends to dental health with Acyclonine MUM, a proven therapy providing targeted relief for oral conditions such as mucosal ulcerations, post-operative pain, and traumatic injuries. Through these innovations, RAM Pharmaceuticals is transforming care across two critical health sectors—and inviting you to join us on this impactful journey.

RAM Pharmaceuticals Inc

Org chart

Teams

Offices

RAM Pharmaceuticals Inc

Org chart

Teams

Offices

Related companies